[Advances in Retinopathy of Prematurity]

Xiao Xuan Xu1, Ya Jun Wu1, Hong Yun Wu2

  • 1Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China.

Insights

Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Recent advances include anti-VEGF therapy, surgical treatments, and new drugs targeting growth factors and receptors.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Neonatology

Background:

  • Retinopathy of prematurity (ROP) is a serious condition causing abnormal blood vessel growth in premature infants' eyes.
  • It is a primary cause of preventable childhood blindness globally.
  • Understanding ROP's pathogenesis has driven significant research.

Purpose of the Study:

  • To review recent advancements in the treatment and management of Retinopathy of Prematurity.
  • To highlight key therapeutic strategies and drug developments for ROP.

Main Methods:

  • Review of current literature on Retinopathy of Prematurity.
  • Analysis of established and emerging treatment modalities.
  • Summary of pharmacological interventions.

Main Results:

  • Anti-vascular endothelial growth factor (anti-VEGF) therapy and surgical interventions are established ROP treatments.
  • Development of various therapeutic agents, including insulin-like growth factor-1, transforming growth factor-β, polyunsaturated fatty acids, and β-adrenergic receptor blockers.
  • Ongoing research continues to refine ROP management.

Conclusions:

  • Significant progress has been made in understanding and treating ROP.
  • A combination of therapies offers improved outcomes for premature infants.
  • Continued research is vital for further reducing ROP-related vision impairment.

Related Concept Videos

Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups


Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.4K
Sample Preparation for Analysis: Advanced Techniques01:08

Sample Preparation for Analysis: Advanced Techniques

Accurate analysis of complex samples often requires advanced preparation techniques to achieve reliable and reproducible results. Samples containing inorganic or organic materials can be challenging to dissolve or decompose effectively. Standard sample preparation methods include acid digestion, fusion, dry ashing, and wet digestion.
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
1.3K
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
506
Mutations01:39

Mutations

Overview
94.4K
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K